abstract |
the present invention relates to combined therapies employing 4-1bb (cd137) agonists, in particular 4-1bbl trimer containing antigen binding molecules, in combination with her-2 targeting agents, the use of such combined therapies for cancer treatment and methods of using combination therapies. |